| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.12 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.098 | 0.08 |